Kary Eldred
Director at Galectin Therapeutics Inc (GALT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$666
Total bought / sold$6K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 9SEC | GALTGalectin Therapeutics Inc | Buy | 30065,682 held (+0%) | $2.70 | $810 | +45.9% |
| Dec 23SEC | GALTGalectin Therapeutics Inc | Buy | 70065,382 held (+1%) | $3.73 | $3K | +5.6% |
| Dec 23SEC | GALTGalectin Therapeutics Inc | Buy | 70065,382 held (+1%) | $3.73 | $3K | +5.6% |
- Buy
Director Kary Eldred bought $3K of GALT at $3.73 — first open-market purchase in our records.